TRAVERE THERAPEUTICS, INC. Other Income and Expense
TRAVERE THERAPEUTICS, INC. (TVTX) reported Other Income and Expense of -$38.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2026-06-30 was -$38.95M.
- TRAVERE THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2026-03-31 was $193.00K, a 87.02% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2025-12-31 was $11.36M, a 2762.22% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2025-09-30 was $783.00K, a 40.37% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2025 was $13.55M, a 308.53% increase from fiscal 2024.
- TRAVERE THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2024 was $3.32M, a 72.42% decline from fiscal 2023.
- TRAVERE THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2023 was $12.03M.
- TRAVERE THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2022 was -$11.34M.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 3 month as first filed | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 6 month as first filed | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 9 month as first filed | Nonoperating Income (Expense) 12 month | Nonoperating Income (Expense) 12 month as first filed | Nonoperating Income (Expense) 34 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$38.95M 10-Q · filed 2026-08-04 | -$38.76M 10-Q · filed 2026-08-04 | -$27.40M derived: sum of 3 quarters · filed 2026-08-04 | -$26.62M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2026-03-31 | $193.00K 10-Q · filed 2026-05-04 | $11.56M derived: sum of 2 quarters · filed 2026-05-04 | $12.34M derived: sum of 3 quarters · filed 2026-05-04 | $12.25M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-12-31 | $11.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $12.15M derived: sum of 2 quarters · filed 2026-02-19 | $12.06M derived: sum of 3 quarters · filed 2026-08-04 | $13.55M 10-K · filed 2026-02-19 | |||||
| 2025-09-30 | $783.00K 10-Q · filed 2025-10-30 | $698.00K derived: sum of 2 quarters · filed 2026-08-04 | $2.19M 10-Q · filed 2025-10-30 | $2.58M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-06-30 | -$85.00K 10-Q · filed 2026-08-04 | $1.41M 10-Q · filed 2026-08-04 | $1.80M derived: sum of 3 quarters · filed 2026-08-04 | $3.11M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-03-31 | $1.49M 10-Q · filed 2026-05-04 | $1.88M derived: sum of 2 quarters · filed 2026-05-04 | $3.20M derived: sum of 3 quarters · filed 2026-05-04 | $1.33M derived: sum of 4 quarters · filed 2026-05-04 | |||||
| 2024-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.71M derived: sum of 2 quarters · filed 2026-02-19 | -$153.00K derived: sum of 3 quarters · filed 2026-02-19 | $3.32M 10-K · filed 2026-02-19 | |||||
| 2024-09-30 | $1.31M 10-Q · filed 2025-10-30 | -$550.00K derived: sum of 2 quarters · filed 2025-10-30 | $2.92M 10-Q · filed 2025-10-30 | $8.63M derived: sum of 4 quarters · filed 2026-02-19 | |||||
| 2024-06-30 | -$1.86M 10-Q · filed 2025-08-06 | $1.61M 10-Q · filed 2025-08-06 | $7.31M derived: sum of 3 quarters · filed 2026-02-19 | $10.67M derived: sum of 4 quarters · filed 2026-02-19 | |||||
| 2024-03-31 | $3.47M 10-Q · filed 2025-05-01 | $9.18M derived: sum of 2 quarters · filed 2026-02-19 | $12.53M derived: sum of 3 quarters · filed 2026-02-19 | $14.62M derived: sum of 4 quarters · filed 2026-02-19 | |||||
| 2023-12-31 | $5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.06M derived: sum of 2 quarters · filed 2026-02-19 | $11.14M derived: sum of 3 quarters · filed 2026-02-19 | $12.03M 10-K · filed 2026-02-19 | |||||
| 2023-09-30 | $3.36M 10-Q · filed 2024-10-31 | $5.44M derived: sum of 2 quarters · filed 2024-10-31 | $6.32M 10-Q · filed 2024-10-31 | $7.45M derived: sum of 4 quarters · filed 2025-02-21 | |||||
| 2023-06-30 | $2.08M 10-Q · filed 2024-08-01 | $2.02M 10-Q · filed 2023-08-03 | $2.97M 10-Q · filed 2024-08-01 | $2.81M 10-Q · filed 2023-08-03 | $4.10M derived: sum of 3 quarters · filed 2025-02-21 | $2.78M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-03-31 | $883.00K 10-Q · filed 2024-05-06 | $793.00K 10-Q · filed 2023-05-04 | $2.01M derived: sum of 2 quarters · filed 2025-02-21 | $698.00K derived: sum of 3 quarters · filed 2025-02-21 | -$830.00K derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$185.00K derived: sum of 2 quarters · filed 2025-02-21 | -$1.71M derived: sum of 3 quarters · filed 2025-02-21 | -$11.34M 10-K · filed 2025-02-21 | -$11.60M 10-K · filed 2023-02-23 | ||||
| 2022-09-30 | -$1.31M 10-Q · filed 2023-11-07 | -$1.38M 10-Q · filed 2022-10-27 | -$2.84M derived: sum of 2 quarters · filed 2023-11-07 | -$12.47M 10-Q · filed 2023-11-07 | -$12.69M 10-Q · filed 2022-10-27 | -$16.55M derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2022-06-30 | -$1.53M 10-Q · filed 2023-08-03 | -$11.32M 10-Q · filed 2023-08-03 | -$15.24M derived: sum of 3 quarters · filed 2024-02-20 | -$19.12M derived: sum of 4 quarters · filed 2024-02-20 | |||||
| 2022-03-31 | -$9.79M 10-Q · filed 2023-05-04 | -$13.71M derived: sum of 2 quarters · filed 2024-02-20 | -$17.59M derived: sum of 3 quarters · filed 2024-02-20 | -$21.24M derived: sum of 4 quarters · filed 2024-02-20 | |||||
| 2021-12-31 | -$3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$7.80M derived: sum of 2 quarters · filed 2024-02-20 | -$11.45M derived: sum of 3 quarters · filed 2024-02-20 | -$17.46M 10-K · filed 2024-02-20 | -$17.92M 10-K · filed 2022-02-24 | ||||
| 2021-09-30 | -$3.88M 10-Q · filed 2022-10-27 | -$7.53M derived: sum of 2 quarters · filed 2022-10-27 | -$13.54M 10-Q · filed 2022-10-27 | -$17.08M derived: sum of 4 quarters · filed 2022-10-27 | |||||
| 2021-06-30 | -$3.65M 10-Q · filed 2022-08-04 | -$9.65M 10-Q · filed 2022-08-04 | -$13.20M derived: sum of 3 quarters · filed 2022-08-04 | -$16.29M derived: sum of 4 quarters · filed 2022-08-04 | |||||
| 2021-03-31 | -$6.00M 10-Q · filed 2022-05-05 | -$9.55M derived: sum of 2 quarters · filed 2022-05-05 | -$12.64M derived: sum of 3 quarters · filed 2022-05-05 | -$15.53M derived: sum of 4 quarters · filed 2022-05-05 | |||||
| 2020-12-31 | -$3.54M 10-K · filed 2021-03-01 | -$6.63M derived: sum of 2 quarters · filed 2021-10-29 | -$9.53M derived: sum of 3 quarters · filed 2021-10-29 | -$12.63M 10-K · filed 2023-02-23 | |||||
| 2020-09-30 | -$3.09M 10-Q · filed 2021-10-29 | -$5.98M derived: sum of 2 quarters · filed 2021-10-29 | -$9.09M 10-Q · filed 2021-10-29 | -$11.14M derived: sum of 4 quarters · filed 2021-10-29 | |||||
| 2020-06-30 | -$2.89M 10-Q · filed 2021-07-29 | -$6.00M 10-Q · filed 2021-07-29 | -$8.05M derived: sum of 3 quarters · filed 2021-07-29 | -$10.63M derived: sum of 4 quarters · filed 2021-07-29 | |||||
| 2020-03-31 | -$3.10M 10-Q · filed 2021-05-06 | -$5.16M derived: sum of 2 quarters · filed 2021-05-06 | -$7.74M derived: sum of 3 quarters · filed 2021-05-06 | -$9.84M derived: sum of 4 quarters · filed 2021-05-06 | |||||
| 2019-12-31 | -$2.06M 10-K · filed 2021-03-01 | -$4.64M derived: sum of 2 quarters · filed 2021-03-01 | -$6.74M derived: sum of 3 quarters · filed 2021-03-01 | -$9.09M 10-K · filed 2022-02-24 | |||||
| 2019-09-30 | -$2.58M 10-K · filed 2021-03-01 | -$4.68M derived: sum of 2 quarters · filed 2021-03-01 | -$7.03M 10-Q · filed 2020-11-05 | -$9.50M derived: sum of 4 quarters · filed 2021-03-01 | |||||
| 2019-06-30 | -$2.10M 10-K · filed 2021-03-01 | -$4.45M 10-Q · filed 2020-07-31 | -$6.92M derived: sum of 3 quarters · filed 2021-03-01 | -$25.44M derived: sum of 4 quarters · filed 2021-03-01 | |||||
| 2019-03-31 | -$2.35M 10-K · filed 2021-03-01 | -$4.82M derived: sum of 2 quarters · filed 2021-03-01 | -$23.34M derived: sum of 3 quarters · filed 2021-03-01 | -$23.94M derived: sum of 4 quarters · filed 2021-03-01 | |||||
| 2018-12-31 | -$2.47M 10-K · filed 2020-02-24 | -$20.99M derived: sum of 2 quarters · filed 2020-02-24 | -$21.59M derived: sum of 3 quarters · filed 2020-02-24 | -$21.83M 10-K · filed 2021-03-01 | |||||
| 2018-09-30 | -$18.52M 10-K · filed 2020-02-24 | -$19.12M derived: sum of 2 quarters · filed 2020-02-24 | -$19.36M 10-Q · filed 2019-10-30 | -$15.22M derived: sum of 4 quarters · filed 2020-02-24 | |||||
| 2018-06-30 | -$602.00K 10-K · filed 2020-02-24 | -$839.00K 10-Q · filed 2019-08-06 | $3.30M derived: sum of 3 quarters · filed 2020-02-24 | -$5.11M derived: sum of 4 quarters · filed 2020-02-24 | |||||
| 2018-03-31 | -$237.00K 10-K · filed 2020-02-24 | $3.90M derived: sum of 2 quarters · filed 2020-02-24 | -$4.51M derived: sum of 3 quarters · filed 2020-02-24 | -$6.06M derived: sum of 4 quarters · filed 2020-02-24 | |||||
| 2017-12-31 | $4.14M 10-K · filed 2019-02-26 | $4.00K 10-K · filed 2018-02-27 | -$4.27M derived: sum of 2 quarters · filed 2019-02-26 | -$5.83M derived: sum of 3 quarters · filed 2019-02-26 | -$4.57M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | -$8.41M 10-K · filed 2019-02-26 | -$9.96M derived: sum of 2 quarters · filed 2019-02-26 | -$8.71M 10-Q · filed 2018-11-01 | -$14.65M derived: sum of 4 quarters · filed 2019-02-26 | |||||
| 2017-06-30 | -$1.56M 10-K · filed 2019-02-26 | -$302.00K 10-Q · filed 2018-08-03 | -$6.24M derived: sum of 3 quarters · filed 2019-02-26 | $4.04M derived: sum of 4 quarters · filed 2019-02-26 | |||||
| 2017-03-31 | $1.25M 10-K · filed 2019-02-26 | -$4.68M derived: sum of 2 quarters · filed 2019-02-26 | $5.59M derived: sum of 3 quarters · filed 2019-02-26 | $15.01M derived: sum of 4 quarters · filed 2019-02-26 | |||||
| 2016-12-31 | -$5.93M 10-K · filed 2018-07-06 | $5.93M 10-K · filed 2017-03-01 | $4.34M derived: sum of 2 quarters · filed 2018-07-06 | $13.76M derived: sum of 3 quarters · filed 2018-07-06 | $632.00K 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $10.27M 10-K · filed 2018-07-06 | -$10.27M 10-Q · filed 2016-11-04 | $19.69M derived: sum of 2 quarters · filed 2018-07-06 | -$5.30M 10-Q · filed 2017-11-07 | $7.51M derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2016-06-30 | $9.42M 10-K · filed 2018-07-06 | -$9.42M 10-Q · filed 2016-08-05 | $4.97M 10-Q · filed 2017-08-09 | -$2.76M derived: sum of 3 quarters · filed 2018-07-06 | $162.07M derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2016-03-31 | -$14.39M 10-K · filed 2018-07-06 | $14.39M 10-Q · filed 2016-05-05 | -$12.18M derived: sum of 2 quarters · filed 2018-07-06 | $152.66M derived: sum of 3 quarters · filed 2018-07-06 | $134.09M derived: sum of 4 quarters · filed 2018-07-06 | ||||
| 2015-12-31 | $2.21M 10-K · filed 2017-03-01 | $167.04M derived: sum of 2 quarters · filed 2017-03-01 | $148.48M derived: sum of 3 quarters · filed 2017-03-01 | $156.22M 10-K · filed 2018-07-06 | |||||
| 2015-09-30 | $164.84M 10-K · filed 2017-03-01 | $146.27M derived: sum of 2 quarters · filed 2017-03-01 | $154.01M 10-Q · filed 2016-11-04 | $143.68M derived: sum of 4 quarters · filed 2017-03-01 | |||||
| 2015-06-30 | -$18.57M 10-K · filed 2017-03-01 | -$18.69M 10-Q · filed 2015-08-10 | -$10.83M 10-Q · filed 2016-08-05 | -$10.95M 10-Q · filed 2015-08-10 | -$21.16M derived: sum of 3 quarters · filed 2017-03-01 | -$17.27M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $7.74M 10-K · filed 2017-03-01 | $7.74M 10-Q · filed 2015-05-11 | -$2.59M derived: sum of 2 quarters · filed 2017-03-01 | $1.29M derived: sum of 3 quarters · filed 2017-03-01 | $27.76M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | -$10.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$6.44M derived: sum of 2 quarters · filed 2017-03-01 | $20.02M derived: sum of 3 quarters · filed 2017-03-01 | -$33.59M 10-K · filed 2017-03-01 | |||||
| 2014-09-30 | $3.89M 10-Q · filed 2015-11-06 | $3.89M 10-Q · filed 2014-11-13 | $30.35M derived: sum of 2 quarters · filed 2015-11-06 | -$23.26M 10-Q · filed 2015-11-06 | -$23.26M 10-Q · filed 2014-11-13 | -$24.85M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-06-30 | $26.46M 10-Q · filed 2015-08-10 | -$27.15M 10-Q · filed 2015-08-10 | -$28.74M derived: sum of 3 quarters · filed 2016-02-26 | -$34.48M derived: sum of 4 quarters · filed 2016-02-26 | |||||
| 2014-03-31 | -$53.61M 10-Q · filed 2015-05-11 | -$55.20M derived: sum of 2 quarters · filed 2016-02-26 | -$60.94M derived: sum of 3 quarters · filed 2016-02-26 | ||||||
| 2013-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$7.33M derived: sum of 2 quarters · filed 2016-02-26 | -$9.78M 10-K · filed 2016-02-26 | -$9.78M 10-K/A · filed 2015-07-09 | -$9.87M 10-K/A · filed 2015-07-09 | ||||
| 2013-09-30 | -$5.74M 10-Q · filed 2014-11-13 | -$8.18M 10-Q · filed 2014-11-13 | |||||||
| 2012-12-31 | -$86.84K 10-K/A · filed 2015-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |